On 5/8/24, Teva Pharmaceutical Industries L (NYSE: TEVA) stock enjoyed a major increase of 12.8%, closing at $15.74. Moreover, exceptionally high trading volume at 406% of normal accompanied the advance. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 12.0% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, TEVA is expected to continue to be a major Value Builder.
Teva Pharmaceutical Industries L has a current Value Trend Rating of A (Highest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Teva Pharmaceutical Industries L has a slightly positive Appreciation Score of 67 and a very high Power Rating of 90, leading to the Highest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment